Calpain activation is required for homocysteine-mediated hepatic degradation of inhibitor I kappa B alpha
- PMID: 19299176
- DOI: 10.1016/j.ymgme.2009.02.005
Calpain activation is required for homocysteine-mediated hepatic degradation of inhibitor I kappa B alpha
Abstract
Hepatic steatosis is a clinical feature observed in severe hyperhomocysteinemic patients. In mice, cystathionine beta synthase (CBS) deficiency, the most common cause of severe hyperhomocysteinemia, is also associated with steatosis, fibrosis and inflammation. Proinflammatory cytokines usually induce apoptosis. However, hyperhomocysteinemia does not increase apoptosis in liver of CBS-deficient mice compared to wild type mice. The aim of the study was to analyze the activation state of the NF-kappaB pathway in liver of CBS-deficient mice and to investigate its possible involvement in anti-apoptotic signals. We analyzed the level of I kappaB alpha in liver of CBS-deficient mice. A co-culture of primary hepatocytes and Kupffer cells was also used in order to investigate how I kappaB alpha degradation occurs in response to homocysteine. We found lower I kappaB alpha level not only in liver of CBS-deficient mice but also in hepatocyte/Kupffer cell co-culture. The homocysteine-mediated I kappaB alpha enhanced proteolysis occurred via calcium-dependent calpains, which was supported by an increased level of calpain activity and a reduced expression of calpastatin in liver of CBS-deficient mice. Intraperitoneal administration of the inhibitor PDTC normalized the expression of two genes induced by NF-kappaB activation, heme oxygenase-1 and cellular inhibitor of apoptosis 2. Moreover, PDTC administration induced an increase of caspase-3 activity in liver of CBS-deficient mice. Our results suggest that hyperhomocysteinemia induces calpain-mediated I kappaB alpha degradation which is responsible for anti-apoptotic signals in liver.
Similar articles
-
Effect of hyperhomocysteinemia on the protein kinase DYRK1A in liver of mice.Biochem Biophys Res Commun. 2009 Jan 16;378(3):673-7. doi: 10.1016/j.bbrc.2008.11.126. Epub 2008 Dec 6. Biochem Biophys Res Commun. 2009. PMID: 19059382
-
Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver.Gastroenterology. 2005 May;128(5):1405-15. doi: 10.1053/j.gastro.2005.02.034. Gastroenterology. 2005. PMID: 15887121
-
Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice.J Hepatol. 2007 Jan;46(1):151-9. doi: 10.1016/j.jhep.2006.07.028. Epub 2006 Sep 22. J Hepatol. 2007. PMID: 17030070
-
The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.J Physiol Pharmacol. 2008 Dec;59 Suppl 9:155-67. J Physiol Pharmacol. 2008. PMID: 19261978 Review.
-
[Steatosis, chronic hepatitis virus C infection and homocysteine].Gastroenterol Clin Biol. 2007 Apr;31(4):415-20. doi: 10.1016/s0399-8320(07)89402-4. Gastroenterol Clin Biol. 2007. PMID: 17483780 Review. French.
Cited by
-
μ-Calpain as a Novel _target for Impairment of Nitric Oxide-Mediated Vascular Relaxation in Diabetes: A Mini Review.J Mol Genet Med. 2015 May;9(2):167. doi: 10.4172/1747-0862.1000167. J Mol Genet Med. 2015. PMID: 26120352 Free PMC article.
-
Homocysteine-lowering gene therapy rescues signaling pathways in brain of mice with intermediate hyperhomocysteinemia.Redox Biol. 2018 Oct;19:200-209. doi: 10.1016/j.redox.2018.08.015. Epub 2018 Aug 25. Redox Biol. 2018. PMID: 30172984 Free PMC article.
-
Corrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia.Mol Genet Metab Rep. 2015 Jan 13;2:51-60. doi: 10.1016/j.ymgmr.2014.12.007. eCollection 2015 Mar. Mol Genet Metab Rep. 2015. PMID: 28649528 Free PMC article.
-
Dyrk1A, a serine/threonine kinase, is involved in ERK and Akt activation in the brain of hyperhomocysteinemic mice.Mol Neurobiol. 2013 Feb;47(1):105-16. doi: 10.1007/s12035-012-8326-1. Epub 2012 Aug 26. Mol Neurobiol. 2013. PMID: 22923366
-
Plasma DYRK1A as a novel risk factor for Alzheimer's disease.Transl Psychiatry. 2014 Aug 12;4(8):e425. doi: 10.1038/tp.2014.61. Transl Psychiatry. 2014. PMID: 25116835 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials